CalciMedica, Inc.
CALC
Rank in Stocks
#30637
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La... CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.
Share Price
$1.52
Last synced: 2026-11-09
Market Cap
$4.77M
Change (1 day)
11.40%
Change (1 year)
-52.80%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade CalciMedica, Inc. (CALC)
Category
Healthcare
EPS for CalciMedica, Inc. (CALC)
EPS as of June 2026 TTM: $-6.90
According to CalciMedica, Inc.'s latest financial reports, its current EPS (TTM) is $-6.90. At the end of 2025 the company had an EPS of $-9.85, a decrease compared to its 2024 EPS of $-6.10.
EPS history for CalciMedica, Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-6.90 | -29.95% |
| 2025 | $-9.85 | 61.48% |
| 2024 | $-6.10 | -84.05% |
| 2023 | $-38.25 | -67.03% |
| 2022 | $-116.00 | -1.94% |
| 2021 | $-118.30 | -67.81% |
| 2020 | $-367.50 | 105.02% |
| 2019 | $-179.25 | 8.31% |
| 2018 | $-165.50 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -326.96% |
US
|
|
| $-7.07 | 2.46% |
US
|
|
| $-5.29 | -23.33% |
AU
|
|
| $12.88 | -286.67% |
BE
|
|
| $21.56 | -412.46% |
NL
|
Questions about CalciMedica, Inc.'s earnings per share (EPS)
What is CalciMedica, Inc.'s earnings per share (EPS)?
CalciMedica, Inc.'s earnings per share (EPS) over the last twelve months is $-6.90, as of Jun 2026.
What was CalciMedica, Inc.'s earnings per share (EPS) in 2025?
In 2025, CalciMedica, Inc.'s earnings per share (EPS) was $-9.85, compared with $-6.10 in 2024.
How has CalciMedica, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, CalciMedica, Inc.'s earnings per share (EPS) was highest in 2024 ($-6.10) and lowest in 2020 ($-367.50).
How does CalciMedica, Inc.'s earnings per share (EPS) compare with similar companies?
CalciMedica, Inc.'s earnings per share (EPS) ($-6.90) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.